Androgen receptor cross-talk with cell signalling pathways

Growth Factors

Volumn 22, Issue 3, 2004, Pages 179-184

  Culig, Zoran ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Androgen receptor; Cell signalling; Cross talk; Growth factor

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYTOKINE; ENZYME ACTIVATOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GROWTH FACTOR; INTERLEUKIN 6; JANUS KINASE; LIGAND; MITOGEN ACTIVATED PROTEIN KINASE; PEPTIDE; PROTEIN KINASE B; STAT PROTEIN;

ADVANCED CANCER; ARTICLE; AUTOCRINE EFFECT; CANCER INHIBITION; GROWTH STIMULATION; HORMONAL THERAPY; HUMAN; LOW DRUG DOSE; METASTASIS; MOLECULAR INTERACTION; PARACRINE SIGNALING; PHYSIOLOGY; PLEIOTROPY; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR SENSITIVITY; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TREATMENT FAILURE; TUMOR GROWTH; TUMOR XENOGRAFT;

ANIMALS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GROWTH SUBSTANCES; HUMANS; INTERLEUKIN-6; LIGANDS; MALE; MAP KINASE SIGNALING SYSTEM; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; POINT MUTATION; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; SIGNAL TRANSDUCTION;

JANUS;

EID: 5744250223     PISSN: 08977194     EISSN: None     Source Type: Journal    
DOI: 10.1080/08977190412331279908     Document Type: Article

References (49)

1. Aronica, S.M. and Katzenellenbogen, B.S. (1993) "Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-I", Mol. Endocrinol. 7, 743-752.
2. Bakin, R.E., Gioeli, D., Bissonette, E.A. and Weber, M.J. (2003) "Attenuation of Ras signaling restores androgen sensitivity to hormone-refractory C4-2 prostate cancer cells", Cancer Res. 63, 1975-1980.
3. Blok, L.J., de Ruiter, P.E. and Brinkmann, A.O. (1998) "Forskolin-induced dephosphorylation of the androgen receptor impairs ligand binding", Biochemistry 37, 3850-3857.
4. Brass, A.L., Barnard, J., Patai, B.L., Salvi, D. and Rukstalis, D.B. (1995) "Androgen up-regulates epidermal growth factor receptor expression and binding affinity in PC3 cells expressing the human androgen receptor", Cancer Res. 55, 3197-3203.
5. Chen, T., Wang, L.H. and Farrar, W.L. (2000) "Interleukin 6 activates androgen receptor-mediated gene expression through a signal transducer and activator of transcription 3-dependent pathway in LNCaP prostate cancer cells", Cancer Res. 60, 2132-2135.
6. Chen, C.D., Welsbie, D.S., Tran, C., Baek, S.H., Chen, R., Vessella, R., Rosenfeld, M.G. and Sawyers, C.L. (2004) "Molecular determinants of resistance to antiandrogen therapy", Nat. Med. 10, 33-39.
7. Craft, N., Shostak, Y., Carcy, M. and Sawyers, C.L. (1999) "A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase", Nat. Med. 5, 280-285.
8. Culig, Z., Hobisch, A., Cronauer, M.V., Radmayr, C., Trapman, J., Hittmair, A., Bartsch, G. and Klocker, H. (1994) "Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor", Cancer Res. 54, 5474-5478.
9. Culig, Z., Hoffmann, J., Erdel, M., Eder, I.E., Hobisch, A., Hittmair, A., Bartsch, G., Utermann, G., Schneider, M.R., Parczyk, K. and Klocker, H. (1999) "Switch from antagonist to agonist of the androgen receptor blocker bicalutamide is associated with prostate tumour progression in a new model system", Br. J. Cancer 81, 242-251.
10. Darne, C., Veyssiere, G. and Jean, C. (1998) "Phorbol ester causes ligand-independent activation of the androgen receptor", Eur. J. Biochem. 256, 541-549.
11. Debes, J.D., Schmidt, L.J., Huang, H. and Tindall, D.J. (2002) "p300 mediates androgen-independent transactivation of the androgen receptor by interleukin-6", Cancer Res. 62, 5632-5636.
12. Degeorges, A., Tatoud, R., Fauvel-Lafeve, F., Podgorniak, M.P., Millot, G., de Cremoux, P. and Calvo, F. (1996) "Stromal cells from human benign prostate hyperplasia produce a growth-inhibitory factor for LNCaP prostate cancer cells, identified as interleukin-6", Int. J. Cancer 68, 207-214.
13. Gioeli, D., Mandell, J.W., Petroni, G.R., Frierson, H.F., Jr. and Weber, M.J. (1999) "Activation of mitogen-activated protein kinase associated with prostate cancer progression", Cancer Res. 59, 279-284.
14. Gioeli, D., Ficarro, S.B., Kwiek, J.J., Aaronson, D., Hancock, M., Catling, A.D., White, F.M., Christian, R.E., Scttlage, R.E., Shabanowitz, J., Hunt, D.F. and Weber, M.J. (2002) "Androgen receptor phosphorylation. Regulation and identification of the phosphorylation sites", J. Biol. Chem. 277, 29304-29314.
15. Gnanapragasam, V.J., Leung, H.Y., Pulimood, A.S., Neal, D.E. and Robson, C.N. (2001) "Expression of RAC3, a steroid hormone receptor coactivator in prostate cancer", Br. J. Cancer 85, 1928-1936.
16. Godoy-Tundidor, S., Hobisch, A., Pfeil, K., Bartsch, G. and Culig, Z. (2002) "Acquisition of agonistic properties of nonsteroidal antiandrogens after treatment with oncostatin M in prostate cancer cells", Clin. Cancer Res. 8, 2356-2361.
17. Gregory, C.W., He, B., Johnson, R.T., Ford, O.H., Mohler, J.L., French, F.S. and Wilson, E.M. (2001) "A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy", Cancer Res. 61, 4315-4319.
18. Gregory, C.W., Fei, X., Ponguta, L.A., He, B., Bill, H.M., French, F.S. and Wilson, E.M. (2004) "Epidermal growth factor increases coactivation of the androgen receptor in recurrent prostate cancer", J. Biol. Chem. 279, 7119-7130.
19. Gupta, C., Chandorkar, A. and Nguyen, A.P. (1996) "Activation of androgen receptor in epidermal growth factor modulation of fetal mouse sexual differentiation", Mol. Cell Endocrinol. 123, 89-95.
20. Hara, T., Miyazaki, J., Araki, H., Yamaoka, M., Kanzaki, N., Kusaka, M. and Miyamoto, M. (2003) "Novel mutations of androgen receptor: a possible mechanism of bicalutamide withdrawal syndrome", Cancer Res. 63, 149-153.
21. Hobisch, A., Eder, I.E., Putz, T., Horninger, W., Bartsch, G., Klocker, H. and Culig, Z. (1998) "Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor", Cancer Res. 58, 4640-4645.
22. Hobisch, A., Ramoner, R., Fuchs, D., Godoy-Tundidor, S., Bartsch, G., Klocker, H. and Culig, Z. (2001) "Prostate cancer cells (LNCaP) generated after long-term interleukin-6 treatment express interleukin-6 and acquire an interleukin-6-partially resistant phenotype", Clin. Cancer Res. 7, 2941-2948.
23. Kim, O., Jiang, T., Xie, Y., Guo, Z., Chen, H. and Qiu, Y. (2004) "Synergism of cytoplasmic kinases in IL-6-induced ligand-independent activation of androgen receptor in prostate cancer cells", Oncogene 23, 1838-1844.
24. Kokontis, J., Takakura, K., Hay, N. and Liao, S. (1994) "Increased androgen receptor activity and altered c-myc expression in prostate cancer cells after long-term androgen deprivation", Cancer Res. 54, 1566-1573.
25. Kollara, A., Diamandis, E.P. and Brown, T.J. (2003) "Secretion of endogenous kallikreins 2 and 3 by androgen receptor-transfected PC-3 prostate cancer cells", J. Steroid Biochem. Mol. Biol. 84, 493-502.
26. Lee, M.S., Igawa, T., Yuan, T.C., Zhang, X.Q., Lin, F.F. and Lin, M.F. (2003a) "ErbB-2 signaling is involved in regulating PSA secretion in androgen-independent human prostate cancer LNCaP C-81 cells", Oncogene 22, 781-796.
27. Lee, S.O., Lou, W., Hou, M., de Miguel, F., Gerber, L. and Gao, A.C. (2003b) "Interleukin-4 enhances prostate-specific antigen expression by activation of the androgen receptor and Akt pathway", Oncogene 22, 6037-6044.
28. Lee, L.F., Louie, M.C., Desai, S.J., Yang, J., Chen, H.W., Evans, C.P. and Kung, H.J. (2004) "Interleukin-8 confers androgen-independent growth and migration of LNCaP: differential effects of tyrosine kinases Src and FAK", Oncogene 23, 2197-2205.
29. Lin, D.L., Whitney, M.C., Yao, Z. and Keller, E.T. (2001) "Interleukin-6 induces androgen responsiveness in prostate cancer cells through up-regulation of androgen receptor expression", Clin. Cancer Res. 7, 1773-1781.
30. Lin, H.K., Hu, Y.C., et al. (2003) "Suppression vs. induction of androgen receptor functions by the phosphatidylinositol 3-kinase/Akt pathway in prostate cancer LNCaP cells with different passage number", J. Biol. Chem. 278, 50902-50907.
31. Lu, S., Tsai, S.Y. and Tsai, M.J. (1997) "Regulation of androgen-dependent prostatic cancer cell growth: androgen regulation of CDK2, CDK4, and CKI p16 genes", Cancer Res. 57, 4511-4516.
32. MacDonald, A. and Habib, F.K. (1992) "Divergent responses to epidermal growth factor in hormone sensitive and insensitive human prostate cancer cell lines", Br. J. Cancer 65, 177-182.
33. Mori, S., Murakami-Mori, K. and Bonavida, B. (1999) "Oncostatin M (OM) promotes the growth of DU 145 human prostate cancer cells, but not PC-3 or LNCaP, through the signaling of the OM specific receptor", Anticancer Res. 19, 1011-1015.
34. Nakhla, A.M., Romas, N.A. and Rosner, W. (1997) "Estradiol activates the prostate androgen receptor and prostate-specific antigen secretion through the intermediacy of sex hormone-binding globulin", J. Biol. Chem. 272, 6838-6841.
35. Nazareth, L.V. and Weigel, N.L. (1996) "Activation of the human androgen receptor through a protein kinase A signaling pathway", J. Biol. Chem. 271, 19900-19907.
36. Nickerson, T., Chang, F., Lorimer, D., Smeekens, S.P., Sawyers, C.L. and Pollak, M. (2001) "In vivo progression of LAPC-9 and LNCaP prostate cancer models to androgen independence is associated with increased expression of insulin-like growth factor-I (IGF-I) and IGF-I receptor (IGF-IR)", Cancer Res. 61, 6276-6280.
37. Okamoto, M., Lee, C. and Oyasu, R. (1997) "Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro", Cancer Res. 57, 141-146.
38. Reinikainen, P., Palvimo, J.J. and Jannc, O.A. (1996) "Effects of mitogens on androgen receptor-mediated transactivation", Endocrinology 137, 4351-4357.
39. Royuela, M., Ricote, M., Parsons, M.S., Garcia-Tunon, I., Paniagua, R. and de Miguel, M.P. (2004) "Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplastic, and malignant human prostate", J. Pathol. 202, 41-49.
40. Sadar, M.D. (1999) "Androgen-independent induction of prostate-specific antigen gene expression via cross-talk between the androgen receptor and protein kinase A signal transduction pathways" , J. Biol. Chem. 274, 7777-7783.
41. Sadar, M.D. and Gleave, M.E. (2000) "Ligand-independent activation of the androgen receptor by the differentiation agent butyrate in human prostate cancer cells", Cancer Res. 60, 5825-5831.
42. Steiner, H., Godoy-Tundidor, S., Rogatsch, H., Berger, A.P, Fuchs, D., Comuzzi, B., Bartsch, G., Hobisch, A. and Culig, Z. (2003) "Accelerated in vivo growth of prostate tumors that up-regulate interleukin-6 is associated with reduced retinoblastoma protein expression and activation of the mitogen-activated protein kinase pathway", Am. J. Pathol. 162, 655-663.
43. Twillie, D.A., Eisenberger, M.A., Carducci, M.A., Hseih, W.S., Kim, W.Y. and Simons, J.W. (1995) "Interleukin-6: a candidate mediator of human prostate cancer morbidity", Urology 45, 542-549.
44. Ueda, T., Bruchovsky, N. and Sadar, M.D. (2002a) "Activation of the androgen receptor N-terminal domain by interleukin-6 vis MAPK and STAT3 signal transduction pathways", J. Biol. Chem. 277, 7076-7085.
45. Ueda, T., Mawji, N.R., Bruchovsky, N. and Sadar, M.D. (2002b) "Ligand-independent activation of the androgen receptor by interleukin-6 and the role of steroid receptor coactivator-1 in prostate cancer cells", J. Biol. Chem. 277, 38087-38094.
46. Veldscholte, J., Ris-Stalpers, C., Kuiper, G.G., Jenster, G., Berrevoets, C., Claassen, E., van Roeij, H.C., Trapman, J., Brinkmann, A.O. and Mulder, E. (1990) "A mutation in the ligand-binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to antiandrogens", Biochem. Biophys. Res. Commun. 173, 534-540, 1990.
47. Wen, Y., Hu, M.C., Makino, K., Spohn, B., Bartholomeusz, G., Yan, D.H. and Hung, M.C. (2000) "HER-2/neu promotes androgen-independent survival and growth of prostate cancer cells through the Akt pathway", Cancer Res. 60, 6841-6845.
48. Ye, D., Mendelsohn, J. and Fan, Z. (1999) "Androgen and epidermal growth factor down-regulate cyclin-dependent kinase inhibitor p27kip1 and costimulate proliferation of MDA PCa 2a and MDA PCa 2b prostate cancer cells", Clin. Cancer Res. 5, 2171-2177.
49. Yeh, S., Lin, H.K., Kang, H.Y., Thin, T.H., Lin, M.F. and Chang, C. (1999) "From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells", Proc. Natl Acad. Sci. USA 96, 5458-5463.